June 14, 2021 — Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly understood that they share common risk factors, including tobacco use, diet, blood pressure, and obesity.

June 14, 2021 — An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac events more accurately than current standard imaging protocols, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

Image from the announcement of the Neal award winner of best technical content for DAIC's coverage of COVID-10 related to cardiology at the Neal virtual award ceremony June 9.

June 10, 2021 — Diagnostic and Interventional Cardiology (DAIC) magazine has won a prestigious Jesse H. Neal Award for its COVID-19 coverage during 2020. DAIC won the award for Best Technical/Scientific Content for its entry "delivering Detailed Medical Information to Clinicians During COVID-19."
GE is integrating artificial intelligence into most of its imaging and information technology software. AI can aid fast critical care decision making. Above left is the vScan Air wireless point-of-care ultrasound system. It integrates AI for immediate, automated assessment of a patient's ejection fraction, right.

The digital transformation of healthcare is underway, but it will advance further and faster if key stakeholders work together. That is the idea behind the Applied Health Innovation Consortium (AHIC) led by the American College of Cardiology (ACC).

June 9, 2021 — AI Med will present its Virtual Clinical Series: Imaging Built by Clinicians, for Clinicians, June 29-30, 2021. This is AI Med’s second CME-accredited, multi-track virtual track of 2021 and will bring together healthcare executives and clinicians specializing in cardiology, radiology, pathology, dermatology and ophthalmology.

AI Med Clinical Series: Imaging Built by Clinicians, for Clinicians

It is brutal and very expensive to bring a new transcatheter valve to market. Boston Scientific invested vast amounts of resources to bring the Lotus transcatheter aortic valve replacement (TAVR) device to the U.S. market. However, the vendor found the Lotus lagged so far behind the first-to-market TAVR valves (the Edwards Lifesciences Sapien and the Medtronic CoreValve) that it was not worth further investment and removed the Lotus from the market in November 2020.

Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no differences is therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI.

Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 American College of Cardiology (ACC) scientific sessions. 

June 7, 2021 — A couple years ago a study showed a mortality safety signal in patients who underwent peripheral artery disease (PAD) revascularization with paclitaxel drug-coated devices. This immediately raised alarm in with the U.S. Food and Drug Administration (FDA) and the interventional community and prompted numerous studies to confirm if there was a mortality signal, or if the findings were just coincidence.

June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral and tricuspid programs, presented as part of the late-breaking clinical trials at EuroPCR and ACC 2021. Both valve programs demonstrated positive outcomes for patients impacted by mitral or tricuspid heart valve disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now